With the analysis among 659 patents, we discovered top 46 key players by total patent application. Theravance Biopharma R&D IP LLC, Novartis AG, Innoviva, Inc. are dominant in this area. They take 74.20% of the total patent filing.
California, United States
Patent: 360
Basel-Stadt, Switzerland
Patent: 67
California, United States
Patent: 62
California, United States
Patent: 16
Jiangsu Sheng, China
Patent: 15
Jiangsu Sheng, China
Patent: 15
Gyeonggi-do, South Korea
Patent: 12
With the analysis among 2 patents, we discovered top 1 start-ups by total patent application.
Guangdong Sheng, China
Patent: 2
With the analysis among related 80 patents applied in the last 5 years. We discover 25 most active companies in this area. The fast-growing Theravance Biopharma R&D IP LLC, Pharmaleads SA, Designed Cells Co. Ltd. take 50.00% of patent filing during this period.
California, United States
Patent: 26
Guangdong Sheng, China
Patent: 3
São Paulo, Brazil
Patent: 2
Basel-Stadt, Switzerland
Patent: 2
Gyeonggi-do, South Korea
Patent: 2
California, United States
Patent: 2
With the analysis among related 80 patents in last 5 years, we discover 15 new entrants. Designed Cells Co. Ltd., J2H Biotech, Inc., Oxford University Innovation Ltd. are the most active new entrants in this area.
Gyeonggi-do, South Korea
Patent: 2
California, United States
Patent: 2
São Paulo, Brazil
Patent: 2
Victoria, Australia
Patent: 1
New York, United States
Patent: 1
Tianjin Shi, China
Patent: 1
With the analysis among 51 patents, we discovered top 10 universities and scientific research institutions by total patent application. Academia Sinica, University of Zurich, The Johns Hopkins University are dominant in this area. They take 33.33% of the total patent filing.
ZURICH, Switzerland
Patent: 4
Colorado, United States
Patent: 2
Queensland, Australia
Patent: 1
Victoria, Australia
Patent: 1
Chiba-ken, Japan
Patent: 1
Shandong Sheng, China
Patent: 1
Tianjin Shi, China
Patent: 1